BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6334686)

  • 21. Deoxy-ATP accumulation in adenosine deaminase-inhibited human B and T lymphocytes.
    Gruber HE; Cohen AH; Firestein GS; Redelman D; Bluestein HG
    Adv Exp Med Biol; 1986; 195 Pt A():503-7. PubMed ID: 3487921
    [No Abstract]   [Full Text] [Related]  

  • 22. Release of adenosine, inosine and hypoxanthine from rabbit non-myelinated nerve fibres at rest and during activity.
    Maire JC; Medilanski J; Straub RW
    J Physiol; 1984 Dec; 357():67-77. PubMed ID: 6512706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATP depletion as a consequence of adenosine deaminase inhibition in man.
    Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of adenosine deaminase activity reveals an intense active transport of adenosine into neurons in primary cultures.
    Hertz L; Matz H
    Neurochem Res; 1989 Aug; 14(8):755-60. PubMed ID: 2812252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
    Plunkett W; Benjamin RS; Keating MJ; Freireich EJ
    Cancer Res; 1982 May; 42(5):2092-6. PubMed ID: 6175407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of nucleotide pool during heart transplantation and evaluation of adenylate catabolic pathways in the human heart.
    Smolenski RT; Suitters A; Lachno DR; Yacoub MH
    Adv Exp Med Biol; 1991; 309A():289-92. PubMed ID: 1789228
    [No Abstract]   [Full Text] [Related]  

  • 27. Adenine nucleotide catabolism in human erythrocytes: pathways and regulation.
    van den Berghe G; Bontemps F
    Biomed Biochim Acta; 1990; 49(2-3):S117-22. PubMed ID: 2167076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breakdown of 5'-adenine nucleotides in ischaemic renal cortex estimated by oxypurine excretion during perfusion.
    Buhl MR; Jörgensen S
    Scand J Clin Lab Invest; 1975 May; 35(3):211-7. PubMed ID: 1153918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro.
    Begleiter A; Pugh L; Israels LG; Johnston JB
    Cancer Res; 1988 Jul; 48(14):3981-6. PubMed ID: 3260129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Phosphorylation of deoxycoformycin and incorporation into cellular DNA.
    Siaw MF; Coleman MS
    J Biol Chem; 1984 Aug; 259(15):9426-33. PubMed ID: 6204981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
    Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitor of 2',5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
    Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
    Biochem Biophys Res Commun; 1985 Mar; 127(3):1019-25. PubMed ID: 3872657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenine nucleotide metabolism and nucleoside transport in human erythrocytes under ATP depletion conditions.
    Plagemann PG; Wohlhueter RM; Kraupp M
    Biochim Biophys Acta; 1985 Jul; 817(1):51-60. PubMed ID: 3873962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenine nucleotide degradation by the obligate intracellular bacterium Rickettsia typhi.
    Williams JC
    Infect Immun; 1980 Apr; 28(1):74-81. PubMed ID: 6247288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
    Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
    Adv Exp Med Biol; 1986; 195 Pt B():683-7. PubMed ID: 3490130
    [No Abstract]   [Full Text] [Related]  

  • 37. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.
    Sabina RL; Swain JL; Olanow CW; Bradley WG; Fishbein WN; DiMauro S; Holmes EW
    J Clin Invest; 1984 Mar; 73(3):720-30. PubMed ID: 6707201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
    Smith CM; Henderson JF
    Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of adenine nucleotide depletion from endothelial cells exposed to reactive oxygen metabolites.
    Aalto TK; Raivio KO
    Free Radic Biol Med; 1993 Feb; 14(2):177-83. PubMed ID: 8381105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine metabolism in human skin fibroblasts.
    Holland MJ; Murphy E; Kelleher JK
    Am J Physiol; 1985 Jan; 248(1 Pt 1):C21-6. PubMed ID: 3881043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.